Quantitative assessment of subcutaneous fibrinolysis in the rat

Journal of Pharmacological Methods
C G KirsteinH Berger

Abstract

A clot lysis model in the rat was described which was responsive to manipulation of the fibrinolytic system. By employing [125I]-labeled fibrinogen in homologous, plasminogen-deficient plasma, clots were prepared in Teflon-perforated cylinders and were implanted subcutaneously. After a brief lag phase, lysis proceeded essentially linearly with 70% of the clot resolved within 12 days. Enhancement of lysis was achieved with a stimulator of fibrinolysis, stanozolol; and inhibition, with the antifibrinolytic, tranexamic acid. Other drugs affecting blood pressure, inflammation, or connective tissue growth had no effect on lysis. Interstitial fluid collected from empty cylinders and fluid obtained from the recovered clots were monitored for plasminogen, alpha 2-antiplasmin, plasminogen activator, and plasminogen activator inhibitor using sensitive and specific assays. All of these fibrinolytic proteins were quantitated relative to their plasma concentrations. The most striking differences between the two fluids and plasma were a threefold higher concentration of the plasminogen activator inhibitor and only traces of free tissue plasminogen activator in the fluids. Nevertheless, significant tissue plasminogen activator was delivered t...Continue Reading

References

Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
May 1, 1975·Atherosclerosis·R N ChakravartiK C Das
May 1, 1972·British Journal of Haematology·J F DavidsonG P McNicol
Jul 1, 1972·Journal of Clinical Pathology·J F DavidsonG P McNicol
Oct 1, 1971·Biochemical Pharmacology·K R CutroneoG C Fuller
Jul 1, 1968·Canadian Journal of Physiology and Pharmacology·K Kowalewski, S Yong
Jul 1, 1969·Canadian Journal of Surgery. Journal Canadien De Chirurgie·K Kowalewski, S Yong
Aug 1, 1969·Experimental and Molecular Pathology·H C Kwaan, T Astrup
Jan 24, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·B WimanM Rånby
Oct 1, 1984·The Journal of Clinical Investigation·L A EricksonD J Loskutoff
Jul 1, 1953·Physiological Reviews·J R PAPPENHEIMER
Apr 1, 1964·The Journal of Pathology and Bacteriology·H C KWAAN, T ASTRUP
Apr 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·L E MUTSCHLER
Aug 1, 1983·Thrombosis Research·J ChmielewskaB Wiman

❮ Previous
Next ❯

Citations

Dec 4, 1992·Annals of the New York Academy of Sciences·C L Jackson, M A Reidy
Aug 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C L JacksonM A Reidy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.